SCHEMBL5455993

SCHEMBL5455993

CC(C)C[C@@H](CO)NC(=O)[C@@H](N)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.47
DPP8 Q6V1X1 2/20 0.47
DPP9 Q86TI2 2/20 0.47
DPP7 Q9UHL4 2/20 0.47
FAP Q12884 1/20 0.47
ANPEP P15144 3/20 0.38
DNPEP Q9ULA0 2/20 0.38
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
SLC7A5 Q01650 2/20 0.36
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
MME P08473 3/20 0.36
RNPEP Q9H4A4 2/20 0.35
CYP3A4 P08684 1/20 0.35
MAPK1 P28482 1/20 0.35
CNR1 P21554 3/20 0.35
TNF P01375 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27555287 1.00 DPP4 (0.47) DPP4DPP8DPP9DPP7FAP
SCHEMBL13016671 0.93 DPP4 (0.42) DPP4DPP8DPP9DPP7FAP
SCHEMBL30019279 0.88 DPP4 (0.53) DPP4DPP8DPP9DPP7FAP
SCHEMBL28412557 0.88 DPP4 (0.53) DPP4DPP8DPP9DPP7FAP
SCHEMBL19439391 0.83 ANPEP (0.42) DPP4DPP8DPP9ANPEPDNPEP
SCHEMBL9572303 0.83 SLC7A5 (0.47) ANPEPDNPEPTAS1R3TAS1R1SLC7A5
SCHEMBL14269010 0.80 TAS1R3 (0.40) ANPEPDNPEPTAS1R3TAS1R1AURKA
SCHEMBL13035554 0.80 TAS1R3 (0.40) ANPEPDNPEPTAS1R3TAS1R1AURKA
SCHEMBL13034816 0.80 TAS1R3 (0.40) ANPEPDNPEPTAS1R3TAS1R1AURKA
SCHEMBL10079223 0.78 MMP1 (0.40) TAS1R3TAS1R1MMECYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293560-A1 Compounds and compositions ABELL ANDREW D 2007-12-20 US disclosed
US-20070293560-A1 Compounds and compositions ABELL ANDREW D 2007-12-20 US disclosed
US-20070293560-A1 Compounds and compositions ABELL ANDREW D 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293560-A1 Compounds and compositions CAPN1, CAPN2, CAPN9 DPP4 452/4885DPP8 499/4885DPP9 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.